Growth Metrics

Larimar Therapeutics (LRMR) Depreciation and Depletion: 2013-2020

Historic Depreciation and Depletion for Larimar Therapeutics (LRMR) over the last 7 years, with Dec 2020 value amounting to $50,000.

  • Larimar Therapeutics' Depreciation and Depletion rose 150.00% to $50,000 in Q4 2020 from the same period last year, while for Dec 2020 it was $155,000, marking a year-over-year increase of 98.72%. This contributed to the annual value of $318,000 for FY2024, which is 2.25% up from last year.
  • Latest data reveals that Larimar Therapeutics reported Depreciation and Depletion of $50,000 as of Q4 2020, which was down 0.00% from $50,000 recorded in Q3 2020.
  • Over the past 5 years, Larimar Therapeutics' Depreciation and Depletion peaked at $107,000 during Q3 2018, and registered a low of -$13,000 during Q2 2019.
  • Its 3-year average for Depreciation and Depletion is $41,167, with a median of $50,000 in 2020.
  • Its Depreciation and Depletion has fluctuated over the past 5 years, first soared by 900.00% in 2016, then crashed by 125.00% in 2019.
  • Over the past 5 years, Larimar Therapeutics' Depreciation and Depletion (Quarterly) stood at $61,000 in 2016, then dropped by 18.03% to $50,000 in 2017, then climbed by 4.00% to $52,000 in 2018, then plummeted by 61.54% to $20,000 in 2019, then spiked by 150.00% to $50,000 in 2020.
  • Its Depreciation and Depletion stands at $50,000 for Q4 2020, versus $50,000 for Q3 2020 and $32,000 for Q2 2020.